2024

The State of Patient Access

MMIT’s Inaugural State of the Industry Survey

Fortunately for patients, there are many pharmaceutical and biotech companies working hard to bring innovative therapies to market. But in today’s reality of increasing payer restrictions and barriers to access, how can companies make sure that much-needed treatments get into the hands of patients in need?

In an attempt to shed light on the current and future patient access landscape, we conducted a comprehensive industry survey alongside our sister company, The Dedham Group. Our goal was to better understand how pharma leaders today are planning for potential access problems tomorrow.

Over 300 pharma and biotech leaders weighed in on both existing and future barriers to access, what keep them awake at night, and what gets them going in the morning. By sharing these insights and our key perspectives on what it all means, our hope is to equip companies with the information they need to power their commercial decision-making—and ensure the right patient gets access to the right treatment at the right time.

2024
Infographic: Overcome Unique Access Barriers

Here's a look at the six therapeutic areas that are generating the most excitement from industry leaders, and the anticipated hurdles to access.

Research Report: The 2024 State of Patient Access

Learn the key findings from our survey along with in-depth analysis of what pharma companies need to know to improve their access strategies.

Blog Post: Understanding Access Barriers in 2024 and Beyond

In this blog, you’ll get the highlights from our survey along with the five key patient access issues that are top of mind for pharma and biotech execs, from increasing payer restrictions to regulatory concerns to exciting yet unknown emerging technologies.

Infographic: Reliance on Real-World Data Across the Product Life Cycle

Our findings show that 72% of pharma companies use real-world data to diagnose market access issues and prioritize interventions.

Infographic: Overcome Unique Access Barriers

Here's a look at the six therapeutic areas that are generating the most excitement from industry leaders, and the anticipated hurdles to access.